Justine McIlroy is a seasoned professional in the healthcare sector, currently serving as a Partner at Coulter Partners since September 2022 and as a Trustee for The Brain Tumour Charity since February 2017. Prior experience includes a partnership at MWM Consulting from April 2015 to August 2022, and a significant tenure at Brunswick Group from May 2005 to February 2015, where Justine held roles as Partner and Co-Head of Healthcare, as well as Director and Associate. Earlier career stages included working as an Associate in Healthcare Investment Banking at Cowen and Company from January 2000 to March 2005, and as an Analyst at EvaluatePharma from September 1999 to March 2000. Justine McIlroy holds a PhD in Molecular Therapeutics and a BSc(Hons) in Pharmacology, both from The University of Edinburgh.